3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
17
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
AZD 6244
12
trametinib
4
mirdametinib
2
fludarabine
2
Lasers, Solid-State
2
Inhalation
2
Deoxycholic Acid
2
Acetylcysteine
2
thymoglobulin
1
talimogene laherparepvec
1
omipalisib
1
lorlatinib
1
fludarabine phosphate
1
encorafenib
1
dabrafenib
1
cabozantinib
1
binimetinib
1
abemaciclib
1
Waiting Lists
1
Vincristine
1
Specimen Handling
1
Sirolimus
1
Rituximab
1
Radiation
1
Polidocanol
1
N-monoacetylcystine
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lovastatin
1
Liquid Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
Sunitinib
×
1 year
×
Clear all
No trials found.